Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
- Conditions
- Central Nervous System Lymphoma
- Registration Number
- NCT00967200
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
RATIONALE: Studying the genes expressed in samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.
PURPOSE: This research study is looking at tissue samples from patients with glioma or other brain tumors.
- Detailed Description
OBJECTIVES:
Primary
* To better understand the pathophysiology of gliomas and identify molecular markers that may predict prognosis and progression or that could identify new therapeutic approaches.
Secondary
* To compare gene expression profiles, in terms of response to treatment, and attempt to isolate subgroups of patients with objective response to certain types of chemotherapy or radiotherapy.
OUTLINE: This is a multicenter study.
Biological samples are collected from patients at time of surgery for diagnostic and/or treatment purposes.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 180
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pathophysiology of gliomas 1 day Pathophysiology of gliomas that may predict prognosis and progression or that could identify new therapeutic
- Secondary Outcome Measures
Name Time Method Identification of molecular 1 day Identification of molecular markers that may predict prognosis and progression or that could identify new therapeutic
Trial Locations
- Locations (2)
CHU Montpellier
🇫🇷Montpellier, France
Clinique Gui de Chauliac
🇫🇷Montpellier, France